Literature DB >> 24510329

Comparison of venous glucose to finger-prick glucose in patients with diabetes under hyperbaric hyperoxic conditions: a pilot study.

David McIlroy1, Neil Banham2.   

Abstract

INTRODUCTION: Blood glucose is commonly measured in diabetic patients undergoing hyperbaric oxygen treatment (HBOT) from a 'finger-prick' capillary sample. Although this method is an accurate reflection of venous glucose under normal conditions it has not been validated under hyperbaric, hyperoxic conditions.
METHODS: Four patients with diabetes mellitus undergoing HBOT had venous blood samples drawn simultaneously with routine capillary samples before, during and immediately after three of four HBOT sessions. The Bland-Altman method of assessing agreement between these two measures was used separately for the three time periods.
RESULTS: The relationship between venous and finger-prick glucose at room air was altered significantly by HBOT. The bias (finger-prick minus venous measurements) was significantly less than zero during the HBOT session but not immediately after completion of the session. Owing to the small sample size, the limits of agreement straddled zero at all time points, although the lower limit was close to zero during treatment (finger measurement appeared to be higher than venous measurement on room air and lower than venous undergoing HBOT).
CONCLUSION: Finger-prick capillary sampling may not be an accurate reflection of venous glucose during HBOT.

Entities:  

Keywords:  Diabetes; blood sugar level; hyperbaric oxygen; patient monitoring

Mesh:

Substances:

Year:  2013        PMID: 24510329

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  2 in total

1.  Evaluation of the Abbot FreeStyle Optium Neo H blood glucose meter in the hyperbaric oxygen environment.

Authors:  Carol R Baines; P David Cooper; Geraldine A O'Rourke; Charne Miller
Journal:  Diving Hyperb Med       Date:  2020-06-30       Impact factor: 0.887

2.  Oxygen toxicity seizure mimics.

Authors:  Kevin Foley; Neil Banham; Samantha Bonnington; Ian Gawthrope
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.